A sudden increase in the number of children experiencing severe hepatitis has caught the attention of national health experts. The Centers for Disease Control and Prevention recently issued an alert to healthcare providers about pediatric patients suffering from significant liver injury who also tested positive for adenovirus.
The Food and Drug Administration (FDA) has limited use of the Johnson & Johnson (J&J) COVID-19 vaccine for adults due to risks associated with blood clots.